Business Context and Reporting Period
This Form 8-K is a Current Report filed by Dynamics Special Purpose Corp. (DYNS) on February 15, 2022. The filing details amendments to the Business Combination Agreement and Support Agreements regarding the proposed merger with Senti Biosciences, Inc. (Senti). The transaction involves a merger where Senti will become a wholly-owned subsidiary of Dynamics Special Purpose Corp.
Key Financial Metrics
This filing is a current report regarding material definitive agreements and does not contain financial statements, revenue, profit, cash flow, or liquidity metrics for the reporting period. The document focuses on legal and structural adjustments to the pending merger.
Material Changes and Agreements
The filing reports two primary amendments executed on February 12, 2022:
- Amendment to Business Combination Agreement:
- Equity Incentive Plan Correction: Adjusted Section 5.7 to clarify the annual increase in shares available for issuance under the New Equity Incentive Plan. The increase is now the lesser of a specified percentage of outstanding shares or a number determined by the Committee.
- Option Grant Adjustments: Modified option award agreements for certain persons to reflect that grants are subject to adjustment. Vesting schedules were clarified: some options vest from the grant date (December 19, 2021), while others vest from the Closing Date.
- Amendment to Senti Support Agreements:
- Extended Lock-Up: Certain Senti Supporting Stockholders agreed to an extended lock-up period of three years following the Closing for shares held on the amendment date or acquired thereafter.
- General Lock-Up: Other shares remain subject to the original 12-month lock-up, which includes an early termination provision if the stock price exceeds $12.00 per share for 20 trading days within a 30-day period (starting 150 days post-closing). The Extended Lock-Up does not have this price-based early termination feature.
Outlook, Risks, and Contingencies
Forward-Looking Statements: The filing contains statements regarding the timing, structure, and benefits of the merger, as well as Senti's product development. These are subject to significant risks and uncertainties.
Key Risks and Contingencies:
- Merger Completion: The transaction is contingent upon stockholder approval and satisfaction of other closing conditions.
- Regulatory and Legal: Risks include the failure to obtain SEC effectiveness for the Registration Statement (Form S-4), potential legal proceedings, and changes in laws or regulations.
- Operational and Market: Risks include the impact of COVID-19, the ability to maintain Nasdaq listing post-merger, and general economic or competitive factors.
- Registration Status: As of the filing date, the Registration Statement filed on February 14, 2022, was not yet effective.
Investor Verification Checklist
- Verify the effectiveness status of the Form S-4 Registration Statement filed on February 14, 2022.
- Review the full text of the BCA Amendment (Exhibit 2.1) and Support Agreement Amendments (Exhibit 10.1) for specific terms regarding equity adjustments and lock-up durations.
- Confirm the outcome of the stockholder vote required to approve the proposed merger.
- Monitor for any updates regarding the $12.00 per share price threshold for the General Lock-Up early termination.
- Assess the impact of the extended three-year lock-up on the liquidity of shares held by Senti Supporting Stockholders.